6:29 PM
 | 
Sep 18, 2013
 |  BC Extra  |  Financial News

Prothena planning follow-on

Prothena Corp. plc (NASDAQ:PRTA) proposed to sell 3.5 million shares in a follow-on underwritten by BofA Merrill Lynch; Credit Suisse; RBC Capital Markets; Wedbush PacGrow; and Roth Capital Partners. If sold at...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >